ImmunityBio Inc. (IBRX) Announces Approval for ANKTIVA® in Macau SAR, China.
Share this article
Corporate
Score 65
Bullish
ImmunityBio Inc. (IBRX) Announces Approval for ANKTIVA® in Macau SAR, China
Mar 25, 2026 14:52 UTC
IBRX, XLV, AMGN
Short term
Related Articles
Score 65
Bullish
Comstock Holding Companies Conference: CHCI details fee-based growth, ParkX surge and new data centers
Mar 25, 17:29
Score 65
Bullish
Electronic Arts’ New Dollar Debt Rallies After $15 Billion Sale
Mar 25, 17:26
Score 35
Microsoft's Diversity Chief Departs Amid AI Transformation Push
Mar 25, 17:21
Score 25
Jim Cramer on Whirlpool Corporation: “I’m Going to Have to Take a Pass”
Mar 25, 17:19
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.